Comprehensive insights into uveal melanoma – risk factors, pathophysiology, prognosis, and diagnostic approaches
DOI:
https://doi.org/10.12775/QS.2024.20.53772Keywords
uveal melanoma, pathophysiology, genetics, metastasis, diagnosisAbstract
Introduction and purpose
Uveal melanoma is the most common primary intraocular neoplasm in adults, which originates from melanocytes and arises from the choroid, ciliary body, or iris. The range of symptoms is wide but there are also asymptomatic cases. Metastases mainly concern the liver, and their occurrence significantly worsens the prognosis. Therefore, early detection is so crucial. This article summarizes significant information regarding epidemiology, pathophysiological processes, and genetic abnormalities underlying the disease. Moreover, we highlight possible clinical manifestations and discuss currently applied diagnostic methods.
Description of the state of knowledge
The average annual incidence worldwide is 6 cases per million. Risk stratification takes into account mutations, chromosomal abnormalities, tumor size, or invasion of adjacent tissues. In clinical practice, several diagnostic modalities are available, such as gonioscopy, indirect ophthalmoscopy, fundus photography, ultrasound biomicroscopy, ocular ultrasonography, optical coherence tomography, angiography, computed tomography, magnetic resonance, and positron emission tomography.
Conclusions
The publications analyzed in this article have shown that uveal melanoma is quite a medical challenge. Understanding the disease pathogenesis and underlying genetic abnormalities that may be the target of drugs, could be of great importance for patients and may constitute a step towards a personalized approach. However, further research is necessary to recognize cancer mechanisms more precisely, expand diagnostic options, and consequently register targeted drugs and develop comprehensive management guidelines, especially for metastatic disease to achieve improved survival outcomes.
References
Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SPs. Uveal melanoma: From diagnosis to treatment and the science in between. Cancer. 2016;122(15): p. 2299-2312. https://doi.org/10.1002/cncr.29727
Spagnolo F, Caltabiano G, Queirolo Ps. Uveal melanoma. Cancer Treat Rev. 2012;38(5): p. 549-553. https://doi.org/10.1016/j.ctrv.2012.01.002
Dogrusöz M, Jager MJ, Damato Bs. Uveal Melanoma Treatment and Prognostication. Asia-Pacific journal of ophthalmology (Philadelphia, Pa). 2017;6(2): p. 186-196. https://doi.org/10.22608/apo.201734
Blum ES, Yang J, Komatsubara KM, Carvajal RDs. Clinical Management of Uveal and Conjunctival Melanoma. Oncology (Williston Park). 2016;30(1): p. 29-32, 34-43, 48.
Souto EB, Zielinska A, Luis M, Carbone C, Martins-Gomes C, Souto SB, Silva AMs. Uveal melanoma: physiopathology and new in situ-specific therapies. Cancer Chemother Pharmacol. 2019;84(1): p. 15-32. https://doi.org/10.1007/s00280-019-03860-z
Mahendraraj K, Shrestha S, Lau CS, Chamberlain RSs. Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012). Clin Ophthalmol. 2017;11: p. 153-160. https://doi.org/10.2147/opth.S120530
Zloto O, Pe'er J, Frenkel Ss. Gender differences in clinical presentation and prognosis of uveal melanoma. Investigative ophthalmology & visual science. 2013;54(1): p. 652-656. https://doi.org/10.1167/iovs.12-10365
Vasalaki M, Fabian ID, Reddy MA, Cohen VM, Sagoo MSs. Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma. Br Med Bull. 2017;121(1): p. 107-119. https://doi.org/10.1093/bmb/ldw053
Rishi P, Koundanya VV, Shields CLs. Using risk factors for detection and prognostication of uveal melanoma. Indian journal of ophthalmology. 2015;63(2): p. 110-116. https://doi.org/10.4103/0301-4738.154373
Logan P, Bernabeu M, Ferreira A, Burnier MN, Jr.s. Evidence for the Role of Blue Light in the Development of Uveal Melanoma. Journal of ophthalmology. 2015;2015: p. 386986. https://doi.org/10.1155/2015/386986
Kaliki S, Shields CL, Mashayekhi A, Ganesh A, Furuta M, Shields JAs. Influence of age on prognosis of young patients with uveal melanoma: a matched retrospective cohort study. European journal of ophthalmology. 2013;23(2): p. 208-216. https://doi.org/10.5301/ejo.5000200
Kaliki S, Shields CL, Shields JAs. Uveal melanoma: estimating prognosis. Indian journal of ophthalmology. 2015;63(2): p. 93-102. https://doi.org/10.4103/0301-4738.154367
Gill HS, Char DHs. Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol. 2012;47(3): p. 246-253. https://doi.org/10.1016/j.jcjo.2012.03.038
Frenkel S, Zloto O, Pe'er J, Barak Vs. Insulin-like growth factor-1 as a predictive biomarker for metastatic uveal melanoma in humans. Investigative ophthalmology & visual science. 2013;54(1): p. 490-493. https://doi.org/10.1167/iovs.12-10228
Amaro A, Gangemi R, Piaggio F, Angelini G, Barisione G, Ferrini S, Pfeffer Us. The biology of uveal melanoma. Cancer and Metastasis Reviews. 2017;36(1): p. 109-140. https://doi.org/10.1007/s10555-017-9663-3
Kaštelan S, Mrazovac Zimak D, Ivanković M, Marković I, Gverović Antunica As. Liver metastasis in uveal melanoma - treatment options and clinical outcome. Front Biosci (Landmark Ed). 2022;27(2): p. 72. https://doi.org/10.31083/j.fbl2702072
Mallone F, Sacchetti M, Lambiase A, Moramarco As. Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma. Cancers (Basel). 2020;12(10). https://doi.org/10.3390/cancers12102761
Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RDs. Uveal melanoma: epidemiology, etiology, and treatment of primary disease. Clin Ophthalmol. 2017;11: p. 279-289. https://doi.org/10.2147/opth.S89591
Damato EM, Damato BEs. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients. Ophthalmology. 2012;119(8): p. 1582-1589. https://doi.org/10.1016/j.ophtha.2012.01.048
Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman Ps. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers (Basel). 2021;14(1). https://doi.org/10.3390/cancers14010096
Berus T, Halon A, Markiewicz A, Orlowska-Heitzman J, Romanowska-Dixon B, Donizy Ps. Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review. Anticancer Res. 2017;37(12): p. 6541-6549. https://doi.org/10.21873/anticanres.12110
Riechardt AI, Kilic E, Joussen AMs. The Genetics of Uveal Melanoma: Overview and Clinical Relevance. Klin Monbl Augenheilkd. 2021;238(7): p. 773-780. https://doi.org/10.1055/a-1513-0789
Harbour JWs. A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol Biol. 2014;1102: p. 427-440. https://doi.org/10.1007/978-1-62703-727-3_22
Peng Y, Croce CMs. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1: p. 15004. https://doi.org/10.1038/sigtrans.2015.4
Bakhoum MF, Curtis EJ, Goldbaum MH, Mischel PSs. BAP1 methylation: a prognostic marker of uveal melanoma metastasis. NPJ Precis Oncol. 2021;5(1): p. 89. https://doi.org/10.1038/s41698-021-00226-8
Kivelä Ts. Diagnosis of uveal melanoma. Dev Ophthalmol. 2012;49: p. 1-15. https://doi.org/10.1159/000330613
Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, Carvajal RD, Belfort RN, Jia R, Shields JA, Damato BEs. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1): p. 24. https://doi.org/10.1038/s41572-020-0158-0
Callaway NF, Mruthyunjaya PJIJoR, Vitreouss. Widefield imaging of retinal and choroidal tumors. 2019;5.
Fallico M, Raciti G, Longo A, Reibaldi M, Bonfiglio V, Russo A, Caltabiano R, Gattuso G, Falzone L, Avitabile Ts. Current molecular and clinical insights into uveal melanoma (Review). Int J Oncol. 2021;58(4): p. 10. https://doi.org/10.3892/ijo.2021.5190
Zupan M, Lavrič A, Pižem J, Andrejčič KNs. Iris Ring Melanoma Presenting as Scleral Pigmentation. Case Rep Ophthalmol Med. 2022;2022: p. 4840380. https://doi.org/10.1155/2022/4840380
Lu JE, Welch RJ, Mishra KK, Daftari IK, Park SSs. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning. Eye (Lond). 2019;33(12): p. 1904-1910. https://doi.org/10.1038/s41433-019-0512-1
Silverman RHs. Focused ultrasound in ophthalmology. Clin Ophthalmol. 2016;10: p. 1865-1875. https://doi.org/10.2147/opth.S99535
Kaliki S, Shields CLs. Uveal melanoma: relatively rare but deadly cancer. Eye (Lond). 2017;31(2): p. 241-257. https://doi.org/10.1038/eye.2016.275
Nanji AA, Mercado C, Galor A, Dubovy S, Karp CLs. Updates in Ocular Surface Tumor Diagnostics. Int Ophthalmol Clin. 2017;57(3): p. 47-62. https://doi.org/10.1097/iio.0000000000000174
Bianciotto C, Shields CL, Guzman JM, Romanelli-Gobbi M, Mazzuca D, Jr., Green WR, Shields JAs. Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases. Ophthalmology. 2011;118(7): p. 1297-1302. https://doi.org/10.1016/j.ophtha.2010.11.011
Tarlan B, Kıratlı Hs. Uveal Melanoma: Current Trends in Diagnosis and Management. Turkish journal of ophthalmology. 2016;46(3): p. 123-137. https://doi.org/10.4274/tjo.37431
Kawali A, Pichi F, Avadhani K, Invernizzi A, Hashimoto Y, Mahendradas Ps. Multimodal Imaging of the Normal Eye. Ocular immunology and inflammation. 2017;25(5): p. 721-731. https://doi.org/10.1080/09273948.2017.1375531
Bindewald-Wittich A, Swenshon T, Carasco E, Dreyhaupt J, Willerding GDs. Blue-Light Fundus Autofluorescence Imaging following Ruthenium-106 Brachytherapy for Choroidal Melanoma. Ophthalmologica. 2020;243(4): p. 303-315. https://doi.org/10.1159/000504715
Singh AD, Belfort RN, Sayanagi K, Kaiser PKs. Fourier domain optical coherence tomographic and auto-fluorescence findings in indeterminate choroidal melanocytic lesions. Br J Ophthalmol. 2010;94(4): p. 474-478. https://doi.org/10.1136/bjo.2009.162636
Shousha MA, Karp CL, Canto AP, Hodson K, Oellers P, Kao AA, Bielory B, Matthews J, Dubovy SR, Perez VL, Wang Js. Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. Ophthalmology. 2013;120(5): p. 883-891. https://doi.org/10.1016/j.ophtha.2012.10.025
Ghassemi F, Mirshahi R, Fadakar K, Sabour Ss. Optical coherence tomography angiography in choroidal melanoma and nevus. Clin Ophthalmol. 2018;12: p. 207-214. https://doi.org/10.2147/opth.s148897
Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, Chieng ND, Patel SP, Joshua AM, Piperno-Neumann Ss. Advances in the clinical management of uveal melanoma. Nat Rev Clin Oncol. 2023;20(2): p. 99-115. https://doi.org/10.1038/s41571-022-00714-1
Mazonakis M, Damilakis Js. Computed tomography: What and how does it measure? European Journal of Radiology. 2016;85(8): p. 1499-1504. https://doi.org/10.1016/j.ejrad.2016.03.002
Tailor TD, Gupta D, Dalley RW, Keene CD, Anzai Ys. Orbital neoplasms in adults: clinical, radiologic, and pathologic review. Radiographics. 2013;33(6): p. 1739-1758. https://doi.org/10.1148/rg.336135502
Mastrogiacomo S, Dou W, Jansen JA, Walboomers XFs. Magnetic Resonance Imaging of Hard Tissues and Hard Tissue Engineered Bio-substitutes. Mol Imaging Biol. 2019;21(6): p. 1003-1019. https://doi.org/10.1007/s11307-019-01345-2
Neupane R, Gaudana R, Boddu SHSs. Imaging Techniques in the Diagnosis and Management of Ocular Tumors: Prospects and Challenges. Aaps j. 2018;20(6): p. 97. https://doi.org/10.1208/s12248-018-0259-9
Hirunpat P, Sanghan N, Hirunpat Ss. White matter: A good reference for the signal intensity evaluation in magnetic resonance imaging for the diagnosis of uveal melanoma. Neuroradiol J. 2020: p. 1971400920973407. https://doi.org/10.1177/1971400920973407
Li X, Wang L, Zhang L, Tang F, Wei Xs. Application of Multimodal and Molecular Imaging Techniques in the Detection of Choroidal Melanomas. Frontiers in oncology. 2020;10: p. 617868. https://doi.org/10.3389/fonc.2020.617868
Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer Ls. Uveal Melanoma Biopsy. A Review. Cesk Slov Oftalmol. 2020;76(6): p. 247-252. https://doi.org/10.31348/2020/9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Natalia Paduszyńska, Anna Dąbrowska, Marta Justyna Gonciarz, Dominika Zaliwska, Magdalena Czach, Agnieszka Aleksandra Strojny, Dominika Karolina Adamiec, Adrianna Kraszkiewicz, Monika Anna Kamińska, Monika Kienanh Do
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 229
Number of citations: 0
